Evidence map›Paper›PMID 20037644›Full record

Trial reportPloS one2009

Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine.

Jedidah Mwacharo, Susanna J Dunachie, Oscar Kai, Adrian V S Hill, Philip Bejon, Helen A Fletcher

Erratum issuedOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania major.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014
    Article
  4. Review
  5. Developmental expression of P5 ATPase mRNA in the mouse.Cellular & molecular biology letters · 2012
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Jedidah MwacharoCentre for Geographical Medical Research, Kenya Medical Research Institute, Kilifi, Kenya. JMwacharo@kilifi.kemri-wellcome.org
Susanna J Dunachie
Oscar Kai
Adrian V S Hill
Philip Bejon
Helen A Fletcher
Jenner Institute · GBKenya Medical Research Institute · KEChurchill Hospital · GBUniversity of Oxford · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundThe T-cell mediated immune response plays a central role in the control of malaria after natural infection or vaccination. There is increasing evidence that T-cell responses are heterogeneous and that both the quality of the immune response and the balance between pro-inflammatory and regulatory T-cells determines the outcome of an infection. As Malaria parasites have been shown to induce immunosuppressive responses to the parasite and non-related antigens this study examined T-cell mediated pro-inflammatory and regulatory immune responses induced by malaria vaccination in children in an endemic area to determine if these responses were associated with vaccine immunogenicity.

methodsUsing real-time RT- PCR we profiled the expression of a panel of key markers of immunogenecity at different time points after vaccination with two viral vector vaccines expressing the malaria TRAP antigen (FP9-TRAP and MVA-TRAP) or following rabies vaccination as a control. PRINCIPAL

findingsThe vaccine induced modest levels of IFN-gamma mRNA one week after vaccination. There was also an increase in FoxP3 mRNA expression in both TRAP stimulated and media stimulated cells in the FFM ME-TRAP vaccine group; however, this may have been driven by natural exposure to parasite rather than by vaccination.

conclusionQuantitative PCR is a useful method for evaluating vaccine induced cell mediated immune responses in frozen PBMC from children in a malaria endemic country. Future studies should seek to use vaccine vectors that increase the magnitude and quality of the IFN-gamma immune response in naturally exposed populations and should monitor the induction of a regulatory T cell response.

Indexed as

Polymerase Chain ReactionVaccinationAntigens, ProtozoanChildChild, PreschoolClone CellsForkhead Transcription FactorsGene DosageGene Expression RegulationHumansHypoxanthine PhosphoribosyltransferaseImmunityInfantInterferon-gammaKenyaMalaria VaccinesAntigens, ProtozoanForkhead Transcription FactorsFOXP3 protein, humanHypoxanthine PhosphoribosyltransferaseInterferon-gammaMalaria VaccinesRabies VaccinesReceptors, ThrombinRNA, Messenger

Identifiers

PMID20037644
PMCPMC2792766
OpenAlexW2115470357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.